Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate-Reference-Cited by-同舟云学术

Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate

Published:2022-09-02 Issue: Volume: Page:
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

van der Pol Karel H.^ORCID,Nijenhuis Marga^ORCID,Soree Bianca,de Boer-Veger Nienke J.,Buunk Anne Marie,Guchelaar Henk-Jan,Risselada Arne,van Schaik Ron H. N.,Swen Jesse J.^ORCID,Touw Daan,van der Weide Jan,van Westrhenen Roos^ORCID,Deneer Vera H. M.,Houwink Elisa J. F.^ORCID,Rongen Gerard A.

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

https://www.nature.com/articles/s41431-022-01180-0.pdf

Reference31 articles.

1. Royal Dutch Pharmacists Association (KNMP): Pharmacogenetic Recommendation Text [cited 2022 2nd of January]. Available from: https://www.knmp.nl/.

2. (EACPT) EAfCPaT. [cited 2022 2nd of January]. Available from: https://www.eacpt.eu/.

3. (EAHP) EAoHP. [cited 2022 2nd of January]. Available from: https://www.eahp.eu/.

4. Amstutz U, Henricks LM, Offer SM, Barbarino J, Schellens JHM, Swen JJ, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 Update. Clin Pharm Ther. 2018;103:210–6.

5. Bank PCD, Caudle KE, Swen JJ, Gammal RS, Whirl-Carrillo M, Klein TE, et al. Comparison of the guidelines of the clinical pharmacogenetics implementation consortium and the Dutch pharmacogenetics working group. Clin Pharm Ther. 2018;103:599–618.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia;European Journal of Pharmaceutical Sciences;2024-11

2. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy;British Journal of Clinical Pharmacology;2024-07-30

3. Co-Occurring Methylenetetrahydrofolate Reductase (MTHFR) rs1801133 and rs1801131 Genotypes as Associative Genetic Modifiers of Clinical Severity in Rett Syndrome;Brain Sciences;2024-06-21

4. Understanding the impact of ABCG2 polymorphisms on drug pharmacokinetics: focus on rosuvastatin and allopurinol;Expert Opinion on Drug Metabolism & Toxicology;2024-06-02

5. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs;European Journal of Human Genetics;2024-04-03